| Detected | Trial | Change |
|---|---|---|
| 2026-05-27 | NCT07483294 Cerebellum-based Imaging Neural Markers for Antipsychotic Response |
Phase changed: [] -> ['PHASE4'] |
| 2026-05-27 | NCT07483294 Cerebellum-based Imaging Neural Markers for Antipsychotic Response |
Trial arms changed: 0 -> 1 |
| 2026-05-23 | NCT06768944 Subjective Experience Following Psilocybin |
Recruitment opened |
| 2026-05-20 | NCT06368726 Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or… |
Sponsor changed: Citlalli Mellado Balanzar -> Spanish Foundation for Neurometrics Development |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT04478838 | "Extended" (Alternate Day) Antipsychotic Dosing | Schizophrenia and Related Disorders | Recruiting |
| NCT04580134 | CLOZAPINE Response in Biotype-1 | Schizophrenia | Recruiting |
| NCT06969755 | Biomarkers to Enhance Early Schizophrenia Treatment | Schizophenia Disorder | Recruiting |
| NCT07483294 | Cerebellum-based Imaging Neural Markers for Antipsychotic Response | Psychosis; Acute | Recruiting |
| Phase 3 | |||
| NCT07565428 | Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative… | Negative Symptoms of Schizophrenia | Recruiting |
| Phase 2 | |||
| NCT06512220 | Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in… | Treatment Resistant Depression | Recruiting |
| NCT06768944 | Subjective Experience Following Psilocybin | Investigating the Importance of the Subjective Psychedelic Experience | Recruiting |
| NCT04105231 | Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use | Dual Diagnosis | Active, Not Recruiting |
| Phase 1 | |||
| NCT07490353 | Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic… | Depression - Major Depressive Disorder | Recruiting |
| NCT07503002 | Shortened LSD Intervention for Major Depressive Disorder | Major Depression Moderate | Not Yet Recruiting |
| NCT06368726 | Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or… | Attention | Enrolling by Invitation |